Kidney Diseases  >>  Cubicin (daptomycin)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cubicin (daptomycin) / Merck (MSD)
NCT00490737: Safety Study to Evaluate Daptomycin in Non-infected Adults Who Are Either on Hemodialysis or Continuous Ambulatory Peritoneal Dialysis (MK-3009-021)

Completed
1
12
NA
daptomycin, Cubicin
Cubist Pharmaceuticals LLC
End-Stage Renal Disease
05/08
05/08
NCT00882557: Study to Evaluate Daptomycin Given During Dialysis and After Dialysis

Completed
1
16
US
daptomycin, Cubicin
Cubist Pharmaceuticals LLC
End-stage Renal Disease, Renal Failure Chronic Requiring Hemodialysis
07/09
07/09

Download Options